Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7531637 IL-31 monoclonal antibodies

Patent 7531637 was granted and assigned to ZymoGenetics on May, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Shirley Rene0

Anthony W. Siadak0

Janine Bilsborough0

Date of Patent

May 12, 2009

0

Patent Application Number

114300660

Date Filed

May 8, 2006

0

Patent Citations Received

US Patent 12084494 Interleukin-31 monoclonal antibodies for veterinary use

0

US Patent 11655291 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

0

US Patent 11673946 Methods of treating a companion animal species comprising administering anti-IL31 antibodies

0

US Patent 11697683 Anti-IL31 antibodies for veterinary use

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to methods of treating pruritic diseases, including but not limited to Contact dermatitis, Atopic Dermatitis, Drug induced delayed type cutaneous allergic reactions, Toxic epidermal necrolysis, Cutaneous T cell Lymphoma, Bullous pemphigoid, Alopecia wereata, Vitiligo, Acne Rosacea, Prurigo nodularis, Scleroderma, Herpes simplex virus, or combination thereof by administering IL-31 monoclonal antibodies. The invention further provides the hybridomas that generate the monoclonal antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7531637 IL-31 monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool